Citation: Ld. Lewis et al., ANTIPROLIFERATIVE EFFECTS OF 2'3'-DIDEOXYCYTIDINE IN HUMAN PANCREATICTUMOR-CELLS, Journal of investigative medicine, 46(3), 1998, pp. 213-213
Authors:
OBROCEA M
DAVIS TH
LEWIS LD
MAURER LH
PIPAS JM
SMITH EL
MEYER LP
HAMMOND S
RIGAS JR
Citation: M. Obrocea et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF DOCETAXEL AND GEMCITABINE IN PATIENTS WITH ADVANCED SOLID TUMORS - A NOVEL 2 WEEK SCHEDULE, Annals of oncology, 9, 1998, pp. 363-363
Citation: Ld. Lewis et al., A POTENTIAL INTRACELLULAR TARGET FOR 2'-3'-DIDEOXYINOSINE (DDL) RELATED PANCREATIC TOXICITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 32-32
Citation: Ms. Chapman et al., LAMOTRIGINE AND PHENOBARBITONE-ASSOCIATED HYPERSENSITIVITY SYNDROME -RESOLUTION WITHOUT CORTICOSTEROIDS, British journal of dermatology, 138(4), 1998, pp. 710-711
Authors:
KOSTRUBSKY VE
LEWIS LD
STROM SC
WOOD SG
SCHUETZ EG
SCHUETZ JD
SINCLAIR PR
WRIGHTON SA
SINCLAIR JF
Citation: Ve. Kostrubsky et al., INDUCTION OF CYTOCHROME P4503A BY TAXOL IN PRIMARY CULTURES OF HUMAN HEPATOCYTES, Archives of biochemistry and biophysics (Print), 355(2), 1998, pp. 131-136
Authors:
KOSTRUBSKY VE
STROM SC
LEWIS LD
WOOD SG
SCHUETZ EG
SCHUETZ JD
SINCLAIR PR
WRIGHTON SA
SINCLAIR JF
Citation: Ve. Kostrubsky et al., EFFECT OF TAXOL ON CYTOCHROME P4503A IN PRIMARY CULTURES OF RAT AND HUMAN HEPATOCYTES, The FASEB journal, 11(9), 1997, pp. 312-312
Citation: Sg. Ericson et al., THE ROLE OF POLYMORPHONUCLEAR NEUTROPHILS (PMNS) IN CLEARANCE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN-VIVO AND IN-VITRO, Experimental hematology, 25(13), 1997, pp. 1313-1325
Authors:
KOSTRUBSKY VE
LEWIS LD
WOOD SG
SINCLAIR PR
WRIGHTON SA
SINCLAIR JF
Citation: Ve. Kostrubsky et al., EFFECT OF TAXOL ON CYTOCHROME-P450 3A AND ACETAMINOPHEN TOXICITY IN CULTURED RAT HEPATOCYTES - COMPARISON TO DEXAMETHASONE, Toxicology and applied pharmacology, 142(1), 1997, pp. 79-86
Authors:
LEWIS PJ
BARRINGTON SF
MARSDEN PK
MAISEY MN
LEWIS LD
Citation: Pj. Lewis et al., A STUDY OF THE EFFECTS OF SUMATRIPTAN ON MYOCARDIAL PERFUSION IN HEALTHY FEMALE MIGRAINEURS USING (NH3)-N-13 POSITRON EMISSION TOMOGRAPHY, Neurology, 48(6), 1997, pp. 1542-1550
Authors:
LEWIS LD
BENIN A
SZUMLANSKI CL
OTTERNESS DM
LENNARD L
WEINSHILBOUM RM
NIERENBERG DW
Citation: Ld. Lewis et al., OLSALAZINE AND 6-MERCAPTOPURINE-RELATED BONE-MARROW SUPPRESSION - A POSSIBLE DRUG-DRUG INTERACTION, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 464-475
Citation: Ld. Lewis et al., DELAYED SEQUELAE AFTER ACUTE OVERDOSES OR POISONINGS - CRANIAL NEUROPATHY RELATED TO ETHYLENE-GLYCOL INGESTION, Clinical pharmacology and therapeutics, 61(6), 1997, pp. 692-699
Authors:
LEWIS LD
MAURER LH
RIGAS JR
BEAULIEU B
NIERENBERG DW
Citation: Ld. Lewis et al., PRELIMINARY DATA ON THE EFFECT OF SCHEDULING ON THE PHARMACOKINETICS OF PACLITAXEL (TAX) COMBINED WITH IFOSFAMIDE (IFX), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 32-32
Authors:
DASCANIO JJ
SHIRES PK
CROFT RS
THATCHER CD
LEWIS LD
Citation: Jj. Dascanio et al., MULTIMEDIA CASE-SIMULATION COMPUTER-PROGRAM FOR TEACHING VETERINARY NUTRITION, Journal of the American Veterinary Medical Association, 211(11), 1997, pp. 1380-1384
Authors:
KOSTRUBSKY VE
LEWIS LD
WOOD SG
SINCLAIR PR
WRIGHTON SA
SINCLAIR JF
Citation: Ve. Kostrubsky et al., EFFECT OF PACITAXEL (TAXOL(TM)) ON CYTOCHROME-P450 3A AND ACETAMINOPHEN TOXICITY IN CULTURED RAT HEPATOCYTES - COMPARISON TO DEXAMETHASONE, The FASEB journal, 10(3), 1996, pp. 2864-2864
Citation: Ld. Lewis, A STUDY OF 5 DAY FRACTIONATED IFOSFAMIDE PHARMACOKINETICS IN CONSECUTIVE TREATMENT CYCLES, British journal of clinical pharmacology, 42(2), 1996, pp. 179-186
Authors:
VALONE FH
KAUFMAN PA
GUYRE PM
LEWIS LD
MEMOLI V
DEO Y
GRAZIANO R
FISHER JL
MEYER L
MROZEKORLOWSKI M
WARDWELL K
GUYRE V
MORLEY TL
ARVIZU C
FANGER MW
Citation: Fh. Valone et al., PHASE IA IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU/, Journal of clinical oncology, 13(9), 1995, pp. 2281-2292
Citation: R. Jagathesan et al., A RETROSPECTIVE ANALYSIS OF THE PREVALENCE OF HIV SEROPOSITIVITY AND ITS DEMOGRAPHICS IN THE NORMAL HEALTHY VOLUNTEER POPULATION OF A PHASE-I CLINICAL DRUG STUDY UNIT, British journal of clinical pharmacology, 39(4), 1995, pp. 463-464
Citation: Gh. Gericke et al., THE TEMPORAL CHANGE OF RHG-CSF PHARMACOKINETICS AND THE RELATIONSHIP WITH ABSOLUTE NEUTROPHIL COUNT (ANC) IN PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Experimental hematology, 23(8), 1995, pp. 872-872
Citation: Ld. Lewis, THE PHARMACOKINETICS OF FRACTIONATED IFOSFAMIDE STUDIED DURING CONSECUTIVE TREATMENT CYCLES, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 175-175
Authors:
LEWIS LD
HAYLOCK DN
MOORE S
TO LB
JUTTNER CA
HUGHES TP
Citation: Ld. Lewis et al., IDENTIFICATION OF NORMAL PRIMITIVE PROGENITORS IN BLOOD AND MOBILIZEDBLOOD IN CHRONIC MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 2085-2085
Citation: Ld. Lewis et al., THE MACROLIDE TRIACETYLOLEANDOMYCIN (TAO) ENHANCES THE IMMUNO-SUPPRESSIVE EFFECT OF CYCLOSPORINE-A (CSA) ON STIMULATED HUMAN-LYMPHOCYTES IN-VITRO, Clinical research, 42(2), 1994, pp. 10000250-10000250
Citation: Ld. Lewis et al., A STUDY OF SELF-POISONING WITH ORAL SALBUTAMOL - LABORATORY AND CLINICAL-FEATURES, Human & experimental toxicology, 12(5), 1993, pp. 397-401